GE HealthCare to Acquire Sofie Biosciences for $945 Million
GE HealthCare announced it will acquire Sofie Biosciences for $945 million to enhance its radiopharmaceutical business. This acquisition aims to strengthen GE HealthCare's position in the radiopharma sector by integrating Sofie's advanced technologies and capabilities. The deal reflects GE's strategic focus on expanding its healthcare portfolio in medical imaging and diagnostics.
Reuters·


